Issues in drug treatment for Alzheimer's disease.

Issues in drug treatment for Alzheimer's disease.

Bibliographic Details
Main Authors:	Mcshane, R, Keene, J, Fairburn, C, Jacoby, R, Hope, T
Format:	Journal article
Language:	English
Published:	1997

Similar Items

Issues in drug treatment for Alzheimer's disease (multiple letters) [14]
by: McShane, R, et al.
Published: (1997)

Natural history of behavioural changes and psychiatric symptoms in Alzheimer's disease. A longitudinal study.
by: Hope, T, et al.
Published: (1999)

Wandering in dementia: a longitudinal study.
by: Hope, T, et al.
Published: (2001)

Death and dementia.
by: Keene, J, et al.
Published: (2001)

Predictors of institutionalization for people with dementia living at home with a carer.
by: Hope, T, et al.
Published: (1998)

Natural history of aggressive behaviour in dementia.
by: Keene, J, et al.
Published: (1999)

Clioquinol for the treatment of Alzheimer's Disease.
by: Jenagaratnam, L, et al.
Published: (2006)

Postmortem serotoninergic correlates of cognitive decline in Alzheimer's disease.
by: Lai, M, et al.
Published: (2002)

Donepezil for the treatment of agitation in Alzheimer's disease.
by: Howard, R, et al.
Published: (2007)

Psychosis of Alzheimer's disease is associated with elevated muscarinic M2 binding in the cortex.
by: Lai, M, et al.
Published: (2001)

Antidiabetic Drugs in the Treatment of Alzheimer’s Disease
by: Michalis Michailidis, et al.
Published: (2022-04-01)

Serotonin transporters are preserved in the neocortex of anxious Alzheimer's disease patients.
by: Tsang, S, et al.
Published: (2003)

Loss of serotonin 5-HT2A receptors in, the temporal cortex correlates with cognitive decline in Alzheimer's disease
by: Lai, K, et al.
Published: (2004)

Preventing Alzheimer's disease-related gray matter atrophy by B-vitamin treatment.
by: Douaud, G, et al.
Published: (2013)

Preventing Alzheimer's disease-related gray matter atrophy by B-vitamin treatment
by: Douaud, G, et al.
Published: (2013)

Diagnostic tests for Alzheimer's disease: Rationale, methodology, and challenges
by: Ritchie, C, et al.
Published: (2010)

Reduced serotonin 5-HT1A receptor binding in the temporal cortex correlates with aggressive behavior in Alzheimer disease.
by: Lai, M, et al.
Published: (2003)

Metal protein attenuating compounds for the treatment of Alzheimer's dementia
by: Sampson, E, et al.
Published: (2012)

Lack of evidence for the efficacy of memantine in mild Alzheimer disease
by: Schneider, L, et al.
Published: (2011)

Changes during treatment for bulimia nervosa: a comparison of three psychological treatments.
by: Jones, R, et al.
Published: (1993)

Synaptic pathology in prefrontal cortex is present only with severe dementia in Alzheimer disease.
by: Minger, S, et al.
Published: (2001)

Alzheimer's disease--current issues.
by: Wilcock, G
Published: (1988)

Effect of cognitive impairment and premorbid intelligence on treatment preferences for life-sustaining medical therapy.
by: Fazel, S, et al.
Published: (2000)

THE STRUCTURE OF WANDERING IN DEMENTIA
by: Hope, T, et al.
Published: (1994)

Potential Drug Delivery Pathways for Treatment of Alzheimer’s Disease
by: Wang Xinying
Published: (2022-01-01)

Socio-economic issues in Alzheimer's disease. Resilience and Alzheimer's
by: Cristian Dinu Popescu, et al.
Published: (2014-12-01)

Lack of evidence for the efficacy of memantine in mild Alzheimer disease.
by: Schneider, L, et al.
Published: (2011)

Loss of serotonin 5-HT2A receptors in the postmortem temporal cortex correlates with rate of cognitive decline in Alzheimer's disease.
by: Lai, M, et al.
Published: (2005)

Brief psychosocial therapy for the treatment of agitation in Alzheimer disease (the CALM-AD trial).
by: Ballard, C, et al.
Published: (2009)

Cell cycle kinesis in lymphocytes in the diagnosis of Alzheimer's disease.
by: Nagy, Z, et al.
Published: (2002)

3 METHODOLOGICAL ISSUES IN THE DEVELOPMENT OF OBSERVER-RATED BEHAVIOR RATING-SCALES - EXPERIENCE FROM THE DEVELOPMENT OF THE RATING-SCALE FOR AGGRESSIVE-BEHAVIOR IN THE ELDERLY
by: Patel, V, et al.
Published: (1995)

Donepezil and memantine for moderate-to-severe Alzheimer's disease
by: Howard, R, et al.
Published: (2012)

Drug treatment of Alzheimer's disease - a clinician's view point
by: Wilcock, G
Published: (1991)

Approaches to rational drug development in Alzheimer's disease.
by: Iversen, L, et al.
Published: (1993)

Perspectives of Alzheimer's disease treatments.
by: Davis, J, et al.
Published: (2008)

Aggressive behaviors in Alzheimer's disease and mild cognitive impairment: Systematic review and meta-analysis
by: Yu, R, et al.
Published: (2018)

Homocysteine as a predictor of cognitive decline in Alzheimer's disease
by: Oulhaj, A, et al.
Published: (2010)

Homocysteine as a predictor of cognitive decline in Alzheimer's disease.
by: Oulhaj, A, et al.
Published: (2010)

Drug repositioning targeting glutaminase reveals drug candidates for the treatment of Alzheimer’s disease patients
by: Abdulahad Bayraktar, et al.
Published: (2023-05-01)

Memantine and cholinesterase inhibitor combination therapy for Alzheimer's disease: a systematic review
by: Farrimond, L, et al.
Published: (2012)